Spirulina protects against Rosiglitazone induced osteoporosis in insulin resistance rats

Diabetes Research and Clinical Practice

Volumn 87, Issue 1, 2010, Pages 38-43

  Gupta, Sumeet ^a   Hrishikeshvan, H J ^b   Sehajpal, Prabodh K ^c  

^a MAHARISHI MARKANDESHWAR DEEMED TO BE UNIVERSITY   (India)

^b KRUPANIDHI COLLEGE OF PHARMACY   (India)

^c GURU NANAK DEV UNIVERSITY   (India)

Author keywords

Diabetes mellitus; Insulin resistance; Osteoporosis; Rat; Rosiglitazone; Spirulina

Indexed keywords

CALCIUM; CHROMIUM; GAMMA LINOLENIC ACID; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHORUS; PLANT EXTRACT; ROSIGLITAZONE; SPIRULINA FUSIFORMIS EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE STRENGTH; CONTROLLED STUDY; DIABETES MELLITUS; GLYCEMIC CONTROL; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; MALE; NONHUMAN; OSTEOPOROSIS; PHARMACODYNAMICS; RAT; SPIRULINA; SPIRULINA FUSIFORMIS; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; BONE DENSITY; DEXAMETHASONE; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; OSTEOPOROSIS; RATS; RATS, WISTAR; SPIRULINA; THIAZOLIDINEDIONES;

EID: 73749085096     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.10.002     Document Type: Article

References (37)

1. Joshi N., Mahajan M., Infection and diabetes. In: Pickup J.C., Williams G. (Eds.), Textbook of Diabetes, 3rd ed., Malden Massachusetts Blackwell Science 2003, vol. 2, pp. 1-16 (Chapter 40).
2. Keen H., Tang N.G., and Tang Fui S. The definition and classification of diabetes mellitus. J. Clin. Endocrinol. Metab. 11 (1982) 279-305
3. Ziv E., Shafrir E., Kalman R., Galer S., and Baron H. Changing patterns of prevalence of insulin resistance in Psammomys obesus, a model of nutritionally induced type 2 diabetes. Metabolism 48 (1999) 1549-1554
4. Cheng D. Prevalance, predisposition and prevention of Type-II diabetes. Nutr. Metab. 18 (2005) 2-29
5. Ramarao P., and Kaul C.L. Insulin resistance: current therapeutic approaches. Drugs Today 35 (1999) 895-911
6. Bailey C.J. Drugs on the horizon for diabesity. Curr. Diabetes Rep. 5 (2005) 353-359
7. Letimann J.M., Moore C.B., Smith-Oliver T.A., Wilkinson W.O., and Wilson T.M. An anti diabetic thiazolidinedione is a highly affinity ligand for peroxisome proliferators activated receptor gamma (PPAR-gamma). J. Biol. Chem. 270 (1995) 12953-12956
8. Lee C.H., Olson P., and Evans R.M. Mini review lipid metabolism, metabolic diseases, peroxisome proliferators-activated receptor. Endocrinology 144 (2003) 2201
9. Rosen E.D., and Spiegelman B.M. PPAR gamma a nuclear regular of metabolism differentiation and cell growth. J. Biol. Chem. 276 (2001) 37731-37734
10. Ren D., Collingwood T.N., Rebor E.J., Wolffe A.P., and Camp H.S. PPAR gamma knock down by engineered transcription factors: exogenous PPAR gamma 2 but not PPAR gamma reactivates adipogenesis. Genes Nev. 16 (2002) 27-32
11. Jiang Y., Johagirdor B., and Rein Hard R.L. Pluripotency of mesenchymal cells derived from adult marrow. Nature 418 (2002) 41-49
12. Bianco P., Riminucci M., Gronthoss, and Robey P.G. Bone marrow stromal stem cells: nature, biology and potential applications. Stem Cells 19 (2001) 180-192
13. Schwartz A.V., SellMeyer D.E., Vittingoff E., Palermo L., Lecka-Czernik B., Feingald K.R., et al. Thiazolidinedione (TZD) use & bone density in older adults with diabetes. J. Clin. Endocrinol. Metab. 91 9 (2006) 3276-3278
14. Lecka-Czemik B., Gubrij I., and Moerman E.A. Inhibition of OSF2/Cb F A/expression terminal osteoblast differentiation by PPAR-gamma2. J. Cell. Biochem. 74 (1999) 357-371
15. Bnouham M., Ziyyat A., Mekhfi H., Tahri A., and Legssyer A. Medicinal plants with potential antidiabetic activity-a review of ten years of herbal medicine research (1990-2000). Int. J. Diabetes Metab. 14 (2006) 1-25
16. Modak M., Dixit P., Londhe J., Ghaskadbi S., and Devasagayam T.P.A. Indian herbs and herbal drugs used for the treatment of diabetes. J. Clin. Biochem. Nutr. 40 (2007) 163-173
17. Hayashi K., Hayashi T., and Kojima I. A natural sulfated polysaccharide, calcium spirulina isolated from Spirulina plantensis: in vitro and ex vivo evaluation of anti-herpes simplex virus and anti-human immuno-deficiency virus activities. AIDS Res. Hum. Retroviruses 12 (1996) 1463-1471
18. Mittal A., Suresh-Kumar P.V., Banerjee S., Rao A.R., and Kumar A. Modulatory potential of Spirulina fusiformis on carcinogenic metabolizing enzymes in swiss albino mice. Phytother. Res. 13 (1999) 111-114
19. Qureshi M.A., Garlich J.D., and Kidd M.T. Dietary Spirulina plantesis enhances humoral and cell mediated immune functions in chickens. Immunopharmacol. Immunotoxicol. 18 (1996) 465-476
20. Simsek N., Karadeniz A., Kalkan Y., Keles O.N., and Unal B. Spirulina platensis feeding inhibited the anemia- and leucopenia-induced lead and cadmium in rats. J. Hazard. Mater. 164 (2009) 1304-1309
21. Verma S., Samarth R., and Panwar M. Evaluation of radioprotective effects of Spirulina in swiss albino mice. Asian. J. Exp. Sci. 20 (2000) 121-126
22. Saxena P.S., and Kumar M. Modulatory potential of Spirulina fusiformis on testicular phosphatases in Swiss albino mice against mercury intoxication. Indian J. Exp. Biol. 42 (2004) 998-1002
23. Shalam M.D., Harish M.S., and Farhana S.A. Prevention of dexamethasone and fructose induced insulin resistance in rats by SH-01D a herbal preparation. Ind. J. Pharmacol. 38 (2006) 419-422
24. Giordano B.P., Thrash W., Hollenbaugh L., Dube W.P., Hodges C., Swain A., et al. Performance of seven blood glucose testing systems at high altitude. Diabetes Educ. 15 (1989) 444-448
25. Kaur G., and Kulkarni S. Anti obesity effect of a polyherbal formulation, OB-200G in female rats fed on cafeteria and atherogenic diets. Ind. J. Pharmacol. 32 (2000) 294-299
26. Allain C.C., Poon L.S., Chan C.S., Richmond W., and Fu P.C. Enzymatic determination of total serum cholesterol. Clin. Chem. 20 (1974) 470-475
27. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
28. Prashantha K.B.R., Praveen T.K., Nanjan M.J., Karvekar M.D., and Suresh B. Serum glucose and triglycerides lowering activity of some novel glitazones against dexamethasone-induced hyperlipidemia and insulin resistance. Ind. J. Pharmacol. 39 (2007) 299-302
29. Wy S.O., Mcy N., Lee S.C., Sanke T., Lee H.K., and Chan J.C.N. Genetics of type2 diabetes mellitus. Hong Kong Med. J. 6 (2000) 69-76
30. Turnbow M.A., Keller S.R., Rice M., and Garner C.W. Dexamethasone down-regulation of insulin receptor substrate-1 in 3T3-L-1 adipocytes. J. Biol. Chem. 269 4 (1994) 2516-2520
31. Tenpe C.R., and Yeole P.G. Comparative evaluation of antidiabetic activity of some marketed polyherbal formulations in alloxan induced diabetic rats. Int. J. Pharm. Tech. Res. 1 (2009) 43-49
32. Ishimi Y., Surgayama F., Ezaki J., Fujioka M., and Wu J. Effects of Spirulina, blue-green alga, on bone metabolism in ovariectomized rats and hind limb-unloaded mice. Biosci. Biotechnol. Biochem. 70 2 (2006) 363-368
33. Anitha L., and Chandra Lekha K.R. Antidiabetic property of spirulina. Diabetol. Croatica 35 2 (2006) 29-33
34. Vincet J.B. The biochemistry of chromium. J. Nutr. (2000) 715-718
35. Panam P., Uliyar M., and Uma Iyer. Role of spirulina in the control of glycemia and lipidemia in type 2 diabetes mellitus. J. Med. Food 4 (2001) 193-199
36. Zhu Y., Qi C., Korenberg J.R., Chen X.N., Noya D., Rao M.S., et al. Structural organization of mouse peroxisome proliferator-activated receptor gamma (m PPAR gamma) gene: alternative promoter use and different splicing yield two m PPAR gamma isoforms. Proc. Natl. Acad. Sci. U.S.A. 92 17 (1995) 7921-7925
37. Rzonca S.O., Suva L.J., Gaddy D., Montague D.C., and Lecka-Czernik B. Bone is the target for the antidiabetic compound rosiglitazone. Endocrinology 145 (2004) 401-406